|
Name |
Citronellyl anthranilate
|
Molecular Formula | C17H25NO2 | |
IUPAC Name* |
3,7-dimethyloct-6-enyl 2-aminobenzoate
|
|
SMILES |
CC(CCC=C(C)C)CCOC(=O)C1=CC=CC=C1N
|
|
InChI |
InChI=1S/C17H25NO2/c1-13(2)7-6-8-14(3)11-12-20-17(19)15-9-4-5-10-16(15)18/h4-5,7,9-10,14H,6,8,11-12,18H2,1-3H3
|
|
InChIKey |
LSJVFMHIFWWGDY-UHFFFAOYSA-N
|
|
Synonyms |
Citronellyl anthranilate; 3,7-Dimethyloct-6-enyl 2-aminobenzoate; 68555-57-7; 6-Octen-1-ol, 3,7-dimethyl-, 2-aminobenzoate; 6-Octen-1-ol, 3,7-dimethyl-, 1-(2-aminobenzoate); 3,7-Dimethyl-6-octen-1-ol-2-aminobenzoate; 151MU54E8I; UNII-151MU54E8I; 3,7-dimethyloct-6-en-1-yl 2-aminobenzoate; EINECS 271-433-2; CITRONELLYLANTHRANILATE; SCHEMBL2419517; FEMA NO. 4086; DTXSID40867674; CHEBI:172321; CITRONELLYL ANTHRANILATE [FHFI]; 3,7-Dimethyl-6-octenyl 2-aminobenzoate #; 2-Aminobenzoic acid 3,7-dimethyl-6-octenyl ester; Q27251666
|
|
CAS | 68555-57-7 | |
PubChem CID | 109467 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 275.4 | ALogp: | 5.9 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 52.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 20 | QED Weighted: | 0.443 |
Caco-2 Permeability: | -4.439 | MDCK Permeability: | 0.00002620 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.084 |
30% Bioavailability (F30%): | 0.095 |
Blood-Brain-Barrier Penetration (BBB): | 0.385 | Plasma Protein Binding (PPB): | 96.87% |
Volume Distribution (VD): | 2.359 | Fu: | 3.51% |
CYP1A2-inhibitor: | 0.964 | CYP1A2-substrate: | 0.297 |
CYP2C19-inhibitor: | 0.943 | CYP2C19-substrate: | 0.27 |
CYP2C9-inhibitor: | 0.853 | CYP2C9-substrate: | 0.565 |
CYP2D6-inhibitor: | 0.581 | CYP2D6-substrate: | 0.511 |
CYP3A4-inhibitor: | 0.768 | CYP3A4-substrate: | 0.16 |
Clearance (CL): | 12.941 | Half-life (T1/2): | 0.075 |
hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.213 |
Drug-inuced Liver Injury (DILI): | 0.132 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.012 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.879 | Carcinogencity: | 0.195 |
Eye Corrosion: | 0.028 | Eye Irritation: | 0.979 |
Respiratory Toxicity: | 0.505 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000319 | 0.533 | D07NAJ | 0.316 | ||||
ENC000160 | 0.492 | D0TZ1G | 0.308 | ||||
ENC001800 | 0.488 | D0GY5Z | 0.304 | ||||
ENC000229 | 0.452 | D0N6CR | 0.299 | ||||
ENC000303 | 0.441 | D06LYG | 0.286 | ||||
ENC000586 | 0.429 | D0M1PQ | 0.286 | ||||
ENC000302 | 0.408 | D0Q7ZG | 0.284 | ||||
ENC000176 | 0.403 | D0B7OD | 0.280 | ||||
ENC000300 | 0.400 | D02YPG | 0.277 | ||||
ENC000311 | 0.400 | D0FN7J | 0.275 |